An Open Label Study to Evaluate the Effects of Ezogabine/Retigabine Added to Existing Anti-epileptic Drug(s) on Urinary Voiding Function in Subjects With Partial Onset Seizures
Clinical trial NCT01607346 · TERMINATED
Trial details
- NCT number
- NCT01607346
- Sponsor
- GlaxoSmithKline
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2013-03-27
- Primary completion
- 2016-11-16
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.